Guo-Ping Tian

878 total citations
24 papers, 475 citations indexed

About

Guo-Ping Tian is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guo-Ping Tian has authored 24 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guo-Ping Tian's work include Cholesterol and Lipid Metabolism (5 papers), MicroRNA in disease regulation (3 papers) and Lipid metabolism and disorders (3 papers). Guo-Ping Tian is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), MicroRNA in disease regulation (3 papers) and Lipid metabolism and disorders (3 papers). Guo-Ping Tian collaborates with scholars based in China, Canada and Japan. Guo-Ping Tian's co-authors include Chao‐Ke Tang, Dawei Zhang, Shilin Tang, Pingping He, Xiao-Hua Yu, Yun-Cheng Lv, Li-Jing Liu, Hong Qian, Xin-Ping Ouyang and Xi‐Long Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Gene.

In The Last Decade

Guo-Ping Tian

23 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo-Ping Tian China 10 194 187 166 109 86 24 475
Vladimir S. Shavva Russia 14 93 0.5× 209 1.1× 127 0.8× 20 0.2× 103 1.2× 33 480
Yingfeng Tu China 11 90 0.5× 217 1.2× 59 0.4× 35 0.3× 29 0.3× 18 385
Zhaohua Cai China 14 67 0.3× 180 1.0× 83 0.5× 18 0.2× 104 1.2× 31 463
Gracjana Krzysiek-Mączka Poland 15 41 0.2× 155 0.8× 179 1.1× 44 0.4× 105 1.2× 29 512
Xiaoping Peng China 11 105 0.5× 265 1.4× 40 0.2× 32 0.3× 35 0.4× 24 424
Xiangjun Zeng China 7 38 0.2× 130 0.7× 55 0.3× 75 0.7× 55 0.6× 18 348
Hangxiang Zhang China 8 45 0.2× 157 0.8× 44 0.3× 36 0.3× 58 0.7× 10 380
Yan-Kun Shi China 12 219 1.1× 309 1.7× 59 0.4× 11 0.1× 138 1.6× 27 556
Xian Guo China 13 169 0.9× 320 1.7× 70 0.4× 14 0.1× 52 0.6× 40 609

Countries citing papers authored by Guo-Ping Tian

Since Specialization
Citations

This map shows the geographic impact of Guo-Ping Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo-Ping Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo-Ping Tian more than expected).

Fields of papers citing papers by Guo-Ping Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo-Ping Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo-Ping Tian. The network helps show where Guo-Ping Tian may publish in the future.

Co-authorship network of co-authors of Guo-Ping Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Guo-Ping Tian. A scholar is included among the top collaborators of Guo-Ping Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo-Ping Tian. Guo-Ping Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yu, et al.. (2022). Interleukin-38 in atherosclerosis. Clinica Chimica Acta. 536. 86–93. 8 indexed citations
2.
Liu, Yiwei, et al.. (2022). Design of Bionic Manta Ray Driven by SMA. 56–61. 1 indexed citations
3.
Zeng, Gaofeng, Peng Zhong, Guo-Ping Tian, et al.. (2021). The Akt Pathway Mediates the Protective Effects of Myeloid Differentiation Protein 1 in Pathological Cardiac Remodelling. ESC Heart Failure. 8(4). 3214–3222. 3 indexed citations
4.
Zhong, Peng, et al.. (2021). Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice. Biochemical and Biophysical Research Communications. 547. 15–22. 9 indexed citations
5.
Tian, Guo-Ping, et al.. (2019). Effect of ischemic preconditioning and ulinastatin infusion on cardiopulmonary function in the elderly after single knee replacement. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Lin, Yongqing, Guo-Ping Tian, Haifeng Zhang, et al.. (2019). Long non‐coding RNA SNHG16 regulates human aortic smooth muscle cell proliferation and migration via sponging miR‐205 and modulating Smad2. Journal of Cellular and Molecular Medicine. 23(10). 6919–6929. 17 indexed citations
7.
Chen, Wei, Gaofeng Zeng, Guo-Ping Tian, et al.. (2019). MicroRNA-183-3p up-regulated by vagus nerve stimulation mitigates chronic systolic heart failure via the reduction of BNIP3L-mediated autophagy. Gene. 726. 144136–144136. 8 indexed citations
8.
Chen, Dong, et al.. (2019). A Novel Compact Microstrip Antenna with an Embeddedλ/4 Resonator. International Journal of Antennas and Propagation. 2019. 1–7. 4 indexed citations
9.
Zhang, Xuhui, et al.. (2017). Design and simulation analysis of a new type of multi-gear pump. 793–798. 1 indexed citations
10.
Zhang, Min, Xiao-Hua Yu, Feng Yao, et al.. (2016). Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages. Acta Biochimica et Biophysica Sinica. 48(4). 363–370. 7 indexed citations
11.
Zhao, Guo-Jun, Zhongcheng Mo, Shilin Tang, et al.. (2014). Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells. Atherosclerosis. 235(2). 519–525. 49 indexed citations
12.
Lv, Yun-Cheng, Yanyan Tang, Juan Peng, et al.. (2014). MicroRNA-19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting ATP-binding cassette transporter A1. Atherosclerosis. 236(1). 215–226. 106 indexed citations
13.
Yu, Xiao-Hua, Li-Jing Liu, Hong Qian, et al.. (2013). Apelin and its receptor APJ in cardiovascular diseases. Clinica Chimica Acta. 428. 1–8. 112 indexed citations
14.
Tian, Guo-Ping, Yanyan Tang, Pingping He, et al.. (2013). The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice. Biochemical and Biophysical Research Communications. 443(2). 428–434. 27 indexed citations
15.
Zhou, Jin, Guo-Ping Tian, Jinge Wang, et al.. (2012). Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cells.. PubMed Central. 4 indexed citations
16.
Tian, Guo-Ping, Wujun Chen, Pingping He, et al.. (2012). MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie. 94(12). 2749–2755. 41 indexed citations
17.
Tian, Guo-Ping, et al.. (2012). [Current progress in lipoprotein lipase and atherosclerosis].. PubMed. 43(5). 345–50. 6 indexed citations
18.
Liu, Zhiqiang, et al.. (2012). The Effects of Highexpression and Knockdown Adipophilin in The Activity of ERK1/2 and Expression of PPARγ and Lipid Accumulation in Cells*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 38(12). 1132–1144. 1 indexed citations
19.
Tian, Guo-Ping. (2009). Development of Cold Bending Steel at Home and Abroad and Its Application in Construction. 1 indexed citations
20.
Wu, Lihua, et al.. (2004). [Clinical characteristics of cerebral infarction in China and Japan].. PubMed. 44(6). 335–41. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026